New Breast Cancer Radiotherapy Technology Confers Higher Complications and Costs Before Effectiveness Proven: A Medicare Data Analysis

, , &
Inquiry: The Journal of Health Care Organization, Provision, and Financing 55:004695801875911 (2018)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Add categories

Keywords

Reprint years

DOI

10.1177/0046958018759115

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,168

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Breast cancer incidence: what do the figures mean?Ann Johnson & Jane Shekhdar - 2005 - Journal of Evaluation in Clinical Practice 11 (1):27-31.
Field notes.Daniel Callahan - 2011 - Hastings Center Report 41 (2):c2-c2.
Decision modelling of economic evaluation of intervention programme of breast cancer.Jung-Chen Chang, Tony H.-H. Chen, Stephen W. Duffy, Amy M.-F. Yen & Sam L.-S. Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1282-1288.
God, disease, and spiritual dilemmas: Reading the lives of women with breast cancer.Megan Eide & Ann Milliken Pederson - 2009 - Zygon 44 (1):85-96.
Concordance of hospital‐based cancer registry data with a clinicians' database for breast cancer.Mingji Zhang, Takahiro Higashi, Hiroshi Nishimoto, Takayuki Kinoshita & Tomotaka Sobue - 2012 - Journal of Evaluation in Clinical Practice 18 (2):459-464.
Freestanding Emergency Departments Are Associated With Higher Medicare Costs: A Longitudinal Panel Data Analysis.Patidar Nitish, Weech-Maldonado Robert, J. O’Connor Stephen, Sen Bisakha, M. Trimm Jerry & A. Camargo Carlos - 2017 - Inquiry: The Journal of Health Care Organization, Provision, and Financing 54:004695801772710.
Fractal based techniques for classification of mammograms and identification of microcalcifications.Shankar Deepa & Thomas Dr Tessamma - unknown
Racing for Consent: A Feminist Relational Analysis of Informed Consent for Nondiagnostic Breast Cancer Research Biopsies.Skye A. Miner - 2017 - International Journal of Feminist Approaches to Bioethics 10 (2):42-60.
Cost-effectiveness of predictive genetic tests for familial breast and ovarian cancer.Nikki Breheny, Elizabeth Geelhoed, Jack Goldblatt & Peter O'Leary - 2005 - Genomics, Society and Policy 1 (2):1-13.
The Effects of Fraud on the Evaluation of Health Care.Paul Jesilow - 2005 - Health Care Analysis 13 (3):239-245.
Optimal two‐stage breast cancer screening for countries with intermediate or low incidence of breast cancer.Shou-Jen Kuo, Tony Hsiu-Hsi Chen, Amy Ming-Fang Yen, Dar-Ren Chen & Li-Sheng Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1345-1352.
Breast cancer screening in younger women: evidence and decision making.J. Mark Elwood - 1997 - Journal of Evaluation in Clinical Practice 3 (3):179-186.
Debating the Desirability of New Biomedical Technologies: Lessons from the Introduction of Breast Cancer Screening in the Netherlands. [REVIEW]Marianne Boenink - 2012 - Health Care Analysis 20 (1):84-102.
Collective Fear, Individualized Risk: the social and cultural context of genetic testing for breast cancer.N. Press, J. R. Fishman & B. A. Koenig - 2000 - Nursing Ethics 7 (3):237-249.
Women’s participation in breast cancer screening in France – an ethical approach.Grégoire Moutel, Nathalie Duchange, Sylviane Darquy, Sandrine de Montgolfier, Frédérique Papin-Lefebvre, Odile Jullian, Jérôme Viguier, Hélène Sancho-Garnier & $authorfirstName $authorlastName - 2014 - BMC Medical Ethics 15 (1):64.

Analytics

Added to PP
2018-03-07

Downloads
10 (#1,197,378)

6 months
6 (#528,006)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references